Press Release
QuidelOrtho to Participate in the Evercore ISI Conference
Nov 16, 2023
SAN DIEGO -- QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team are scheduled to participate in the Evercore ISI conference in Miami, FL, on November 30, 2023.
Douglas Bryant, President and Chief Executive Officer, will participate in a fireside chat scheduled for 9:10 a.m. ET / 6:10 a.m. PT.
Interested parties can access the live webcast and replay, which will be available for 90 days, on the “Events & Presentations” section of the “Investor Relations” page of QuidelOrtho’s website at https://ir.quidelortho.com/.
